These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 39039065)

  • 1. Advances in the study of phencyclidine-induced schizophrenia-like animal models and the underlying neural mechanisms.
    Li D; Pan Q; Xiao Y; Hu K
    Schizophrenia (Heidelb); 2024 Jul; 10(1):65. PubMed ID: 39039065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia.
    Jodo E
    J Physiol Paris; 2013 Dec; 107(6):434-40. PubMed ID: 23792022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats.
    Amitai N; Kuczenski R; Behrens MM; Markou A
    Neuropharmacology; 2012 Mar; 62(3):1422-31. PubMed ID: 21238466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of medial prefrontal cortex by phencyclidine is mediated via a hippocampo-prefrontal pathway.
    Jodo E; Suzuki Y; Katayama T; Hoshino KY; Takeuchi S; Niwa S; Kayama Y
    Cereb Cortex; 2005 May; 15(5):663-9. PubMed ID: 15342431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term adaptation of prefrontal circuits in a mouse model of NMDAR hypofunction.
    Ponserre M; Ionescu TM; Franz AA; Deiana S; Schuelert N; Lamla T; Williams RH; Wotjak CT; Hobson S; Dine J; Omrani A
    Neuropharmacology; 2024 Aug; 254():109970. PubMed ID: 38685343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained NMDA receptor hypofunction impairs brain-derived neurotropic factor signalling in the PFC, but not in the hippocampus, and disturbs PFC-dependent cognition in mice.
    Tanqueiro SR; Mouro FM; Ferreira CB; Freitas CF; Fonseca-Gomes J; Simões do Couto F; Sebastião AM; Dawson N; Diógenes MJ
    J Psychopharmacol; 2021 Jun; 35(6):730-743. PubMed ID: 34008450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phencyclidine administration during neurodevelopment alters network activity in prefrontal cortex and hippocampus in adult rats.
    Kjaerby C; Hovelsø N; Dalby NO; Sotty F
    J Neurophysiol; 2017 Aug; 118(2):1002-1011. PubMed ID: 28539393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine.
    Kargieman L; Santana N; Mengod G; Celada P; Artigas F
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14843-8. PubMed ID: 17785415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optogenetic inhibition of ventral hippocampal neurons alleviates associative motor learning dysfunction in a rodent model of schizophrenia.
    Fan ZL; Wu B; Wu GY; Yao J; Li X; Hu KH; Zhou ZH; Sui JF
    PLoS One; 2019; 14(12):e0227200. PubMed ID: 31891640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phencyclidine inhibits the activity of thalamic reticular gamma-aminobutyric acidergic neurons in rat brain.
    Troyano-Rodriguez E; Lladó-Pelfort L; Santana N; Teruel-Martí V; Celada P; Artigas F
    Biol Psychiatry; 2014 Dec; 76(12):937-45. PubMed ID: 25038984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine.
    Takahata R; Moghaddam B
    Neuropsychopharmacology; 2003 Jun; 28(6):1117-24. PubMed ID: 12700703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia-like GABAergic gene expression deficits in cerebellar Golgi cells from rats chronically exposed to low-dose phencyclidine.
    Bullock WM; Bolognani F; Botta P; Valenzuela CF; Perrone-Bizzozero NI
    Neurochem Int; 2009 Dec; 55(8):775-82. PubMed ID: 19651169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal phencyclidine treatment induces behavioral deficits through impairment of GABAergic interneurons in the prefrontal cortex.
    Toriumi K; Oki M; Muto E; Tanaka J; Mouri A; Mamiya T; Kim HC; Nabeshima T
    Psychopharmacology (Berl); 2016 Jun; 233(12):2373-81. PubMed ID: 27095448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats.
    Abekawa T; Ito K; Nakagawa S; Koyama T
    Psychopharmacology (Berl); 2007 Jun; 192(3):303-16. PubMed ID: 17340116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDA antagonist and antipsychotic actions in cortico-subcortical circuits.
    Kargieman L; Santana N; Mengod G; Celada P; Artigas F
    Neurotox Res; 2008 Oct; 14(2-3):129-40. PubMed ID: 19073421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment.
    Thomsen MS; Christensen DZ; Hansen HH; Redrobe JP; Mikkelsen JD
    Neuropharmacology; 2009; 56(6-7):1001-9. PubMed ID: 19233218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
    Nabeshima T; Mouri A; Murai R; Noda Y
    Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Clozapine and Novel Glutamate Modulator JNJ-46356479 on Nitrosative Stress in a Postnatal Murine Ketamine Model of Schizophrenia.
    Treder N; Martínez-Pinteño A; Rodríguez N; Arbelo N; Madero S; Gómez M; García-Rizo C; Mas S; Gassó P; Parellada E; Morén C
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic phencyclidine treatment induces long-lasting glutamatergic activation of VTA dopamine neurons.
    Uramura K; Maejima Y; Shimomura K; Santoso P; Katsuda S; Kobayashi D; Jodo E; Kodaira M; Otgon-Uul Z; Yang Y; Sakuma K; Takigawa M; Hazama A; Yada T
    Neurosci Lett; 2014 Apr; 564():72-7. PubMed ID: 24525246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments.
    Castañé A; Santana N; Artigas F
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4085-97. PubMed ID: 25943167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.